ABSTRACT BACKGROUND: Marijuana is the most widely used illicit drug in the United States and all over the world. Reports indicate that the potency of cannabis preparation has been increasing. This report examines the concentration of cannabinoids in illicit cannabis products seized by the U.S. Drug Enforcement Administration over the last 2 decades, with particular emphasis on Δ 9 -tetrahydrocannabinol and cannabidiol. METHODS: Samples in this report were received over time from materials confiscated by the Drug Enforcement Administration and processed for analysis using a validated gas chromatography with flame ionization detector method. RESULTS: Between January 1, 1995, and December 31, 2014, 38,681 samples of cannabis preparations were received and analyzed. The data showed that although the number of marijuana samples seized over the last 4 years has declined, the number of sinsemilla samples has increased. Overall, the potency of illicit cannabis plant material has consistently increased over time since 1995 from 4% in 1995 to 12% in 2014. The cannabidiol content has decreased on average from .28% in 2001 to ,.15% in 2014, resulting in a change in the ratio of Δ 9 -tetrahydrocannabinol to cannabidiol from 14 times in 1995 to 80 times in 2014. CONCLUSIONS: There is a shift in the production of illicit cannabis plant material from regular marijuana to sinsemilla. This increase in potency poses higher risk of cannabis use, particularly among adolescents.
-THC or THC) concentration over time, has been the subject of occasional reports from our group since 1984 (1) (2) (3) (4) . The importance of monitoring the potency of confiscated cannabis preparations, used as a measure of what is actually being used by the public, lies in the perceived negative health consequences of the use of the more potent products. This topic is addressed in other parts of this special issue.
Although cannabis has been reported to contain .500 different compounds (546 compounds as of last count) belonging to a diverse group of chemical classes, the most important of which is the cannabinoids (104 cannabinoids) (5), the potency of cannabis is usually judged based on the THC content of the preparation. Other constituents have pharmacologic properties of their own, but they are not the subject of this report. Different cannabis preparations are found in the illicit market. These include cannabis (marijuana, sinsemilla, and ditchweed), hashish (the resinous parts of the plants mixed with some plant particles and shaped into different forms depending on the preparation method), and hash oil (concentrated extract of cannabis plant material or hashish as an oil or semisolid preparation).
In our previous publication looking at potency trends (4), we reviewed the status of cannabis potency in the illicit market in the United States as well as in Europe and other countries around the world. The data from the United States was based on our own findings, ending in 2009, and data from the other countries were based on literature reports. Although the potency of cannabis has increased dramatically over the years, resulting in negative impact on the users (6), the literature is rich with many studies showing efficacy and biological activity of therapeutic potential using cannabis preparations with much lower potency (1.5%-4% THC).
In this article, the focus is on the status of cannabis potency in the United States, as this is where most potency data have been generated. Furthermore, although previous potency reports from our group included data from samples provided from the U.S. Drug Enforcement Administration (DEA) seizures as well as samples provided by state law enforcement agents through the cannabis eradication program, this article focuses on potency trends using only the DEA seized materials. These samples provide more realistic data because the seizures are made as the materials were on the way to illicit market distribution. Although the main cannabinoids of interest in cannabis are THC and cannabidiol (CBD), analysis is carried out for all major cannabinoids to have a good understanding of the chemical profile of all samples, which might affect the overall biological activity of the drug.
METHODS AND MATERIALS

Samples
All samples in this report were received from the DEA and provided to our laboratory (under contract with the National Institute on Drug Abuse) by DEA regional laboratories. The DEA kept the samples in climate-controlled storage at 41C before sending them to our laboratory at the University of Mississippi. At our laboratory, the samples were also stored in a climate-controlled vault at 41C. During the period January 1, 1995, to December 31, 2014, 39,985 cannabis preparations (cannabis plant material, hashish, and hash oil) were received from eight DEA regional laboratories (Table 1) ; 38,681 of these cannabis samples were analyzed ( Table 2) .
The description of each sample type of cannabis product received for analysis is listed:
Marijuana-male or female cannabis grown for illicit drug use.
Sinsemilla-female cannabis plants that have not been pollinated; may grow from cutting or from seed; may contain some seed (if unpollinated, the seed will be sterile). Cannabis Potency Over the Last 2 Decades in U.S.
Kilobrick-pressed cannabis made of leaves, heads, stems, and seeds.
Thai sticks-a form of cannabis from Thailand consisting of premium buds of seedless marijuana in which the leaves and buds are tied on the stems to secure the plant material.
Hashish-a concentrated resin cake or ball produced from pressed kief, the detached trichomes and fine material that falls off the cannabis flowers and leaves. It varies in color from black to golden brown depending on the purity and variety of cultivar from which it was obtained.
Hash oil-obtained from the cannabis plant by solvent extraction and contains the cannabinoids present in the natural oils of cannabis flowers and leaves. The solvents are evaporated to leave behind very concentrated oil.
Ditchweed-unattended, wild male and female fiber-type cannabis (hemp) that is native to many Midwestern states.
Gas Chromatography With Flame Ionization Detector Analysis
The analytical method has been previously described (3) . A Varian gas chromatograph with a flame ionization detector (Varian, Inc.) was used for the analysis. Quantitative analysis of seven of the major cannabinoids in cannabis (Δ 9 -THC, Δ 8 -tetrahydrocannabinol, tetrahydrocannabivarin, CBD, cannabichromen, cannabigerol, and cannabinol) was carried out by solvent extraction followed by analysis using capillary gas chromatography, a method offering short analysis time and resolution of all cannabinoids on a single column. Two samples (100 mg each) were used for analysis from each manicured potency monitoring (PM) sample. A 3.0-mL of internal standard (IS) extraction solvent (100 mg 4-androstene-3,17-dione 1 10 mL chloroform 1 90 mL methanol) was added to the sample and allowed to rest at room temperature for 1 hour. The extract was then filtered through a cotton plug, and the clear filtered material was transferred to an autosampler vial. Samples were placed onto the gas chromatograph along with vials of ethanol, IS/Δ 9 -THC mixture (unextracted standard), and controls. Lastly, the results were calculated by obtaining an average percentage of each cannabinoid from the two chromatograms of each PM sample. The response factor for the cannabinoids relative to IS is 1. Therefore, the area of each cannabinoid divided by that of the I.S. multiplied by the amount of IS added (3 mg) gives the percentage of each cannabinoid in the sample, as 100 mg of sample is used for analysis. For example, a cannabinoid with the same peak area as that of the IS represents a 3% concentration in the sample. The method has been validated to meet U.S. Food and Drug Administration Good Manufacturing Practices requirements.
Statistical Analysis
Statistical analysis of data was performed using Normal Distribution function of Microsoft Excel (Microsoft Corp, Redmond, Washington).
RESULTS
The first PM sample was received for analysis in 1975. In past years, confiscated marijuana samples were sent to the project from national, state, and local law enforcement agencies, but because of funding restrictions, as of August 2010, only samples from the DEA regional laboratories are processed for analysis. A database to record information of each sample was established by the University of Mississippi School of Pharmacy data center. The samples are assigned a PM number by the database. Data such as seizure location (city and state), seizure amount, seizure date, case number, exhibit number, and identification of type of sample (e.g., bud, sinsemilla, kilobrick, maturity level, hashish, hash oil) are entered to describe the sample. At the present time, there are 54 fields of information entered to describe each sample. The samples are then prepared for analysis. Technologic advances over the years have made it possible to increase the information recorded for each sample. The most recent database is on the Web and can be viewed by a selected Cannabis Potency Over the Last 2 Decades in U.S.
group. The database has the capability to be downloaded into a program (e.g., Excel), making it possible to prepare graphs and tables. The database program also has the capability to prepare many of the reports required by the National Institute on Drug Abuse and other federal agencies. Although the database includes samples received from DEA specimens as well as samples from domestic cannabis eradication programs administered by different state law enforcement agencies, this report deals only with DEA seized samples, representing approximately two thirds of the total number of samples. These samples have been referred to in some of our previous reports as nondomestic samples (the country of production of those samples is unknown) to distinguish them from the known domestically produced samples.
Between January 1, 1995, and December 31, 2014 (20-year period), 38,681 samples of cannabis preparations (37,606 cannabis plant material, 814 hashish, and 261 hash oil samples) were received, submitted by eight DEA regional laboratories. All the cannabis samples (37,606) of different categories were analyzed. The main categories are marijuana (26,145 samples) and sensimilla (11,344 samples), and the rest of the samples were ditchweed (115 samples) and unknown (2 samples). Under an agreement between the National Institute on Drug Abuse and the DEA, our laboratory is to receive a 25-g sample from the evidence submitted to the regional laboratories of each DEA marijuana seizure .75 g and a 2-g sample from each hashish and hash oil seizure. Table 1 shows the number of samples, by category (cannabis, hashish, or hash oil), received from each of the eight DEA regional Most of the samples are in the cannabis (plant material) category, and hash oil has the highest Δ 9 -THC content followed by hashish and then cannabis. Table S1 in Supplement 1 shows a breakdown of the cannabis samples by type. Marijuana and sinsemilla are where most of the samples reside. Table 2 shows the average concentration of THC and other major cannabinoids in cannabis samples by year, depicting the constant trend of increased potency of cannabis over time, starting from 4% in 1995 and increasing to 12% in 2014. The graph shown in Figure 1 depicts this trend. There was no trend one way or the other for the content of the other cannabinoids except for CBD, which has shown a general decline over the last decade, going from .5% in 2004 to ,.2% in 2014, and the cannabigerol concentration, which has increased from .13% in 1995 to .46% in 2014 (Figure 2) . Table S2 in Supplement 1 shows the average THC content of cannabis samples by type of preparation of each of its two major categories, marijuana and sinsemilla; by year seized; and by number of samples. It is evident from Table S2 that although the number of samples in the marijuana type showed a strong declining trend (p 5 .051) over the last decade, the number of sinsemilla samples showed a strong trend of increase (p 5 .056). Because of the much higher potency of sinsemilla than marijuana, the increase in the proportionate number of sinsemilla samples versus marijuana has been the cause of the overall increase in potency of confiscated samples. Figure 3 shows the proportion of the number of marijuana versus sinsemilla samples seized by year. On examination of the prevalence of high-potency cannabis samples over time, it is clear that the proportion of the higher potency samples (7%-12% and .12% THC) has been increasing over time. Table 3 shows the prevalence of samples of THC concentration of ,3%, 3%-7%, 7%-12%, and .12%. Figure 4 shows a graphic representation of the potency distribution of cannabis samples over the period of this report. The percentage of ,3% samples and 3%-7% samples has been declining over time, whereas the percentage of 7%-12% samples and .12% samples has been increasing, resulting in an overall increase in the potency of confiscated cannabis over the years.
Domestically produced materials are seized in many cases as the plants are still in production. Therefore, the degree of maturity and the THC content for many of these specimens is not reflective of what the potency would be at the time of distribution. We have examined the average potency of mature cannabis samples from domestically produced materials seized in states that have legalized marijuana for medical use versus states where marijuana is still illegal. We found the average Δ
9
-THC concentration for the period 1995-2010 to be 8.73% 6 6.08% for samples from states with laws allowing medical use of the drug and 5.42% 6 4.90% for samples from states still operating under the federal law.
An additional important cannabinoid in cannabis of current interest is CBD. There has been significant interest in CBD over the last few years and in cannabis preparations of high CBD content because of the reported activity of CBD as an antiepileptic agent (7, 8) , particularly its promise for the treatment of intractable pediatric epilepsy (9) . Furthermore, it is perceived by some investigators that marijuana users prefer, or use, materials that have reasonably high levels of CBD along with THC. Examining the CBD content in the cannabis samples over the years does not support this notion. As shown in Figure 2 , the CBD concentration has declined from .5% in 2004 to ,.2% in 2014. Figure 5 shows the distribution of the number of cannabis samples by CBD content against the overall average by year. Although confiscated cannabis samples generally have low CBD content, its concentration has declined even further in the last few years. Plotting the ratio of THC to CBD over time ( Figure 6 ) shows the ratio increased from 15 to almost 80 over the study period. This finding indicates that the drug-using community and the cannabis producers are breeding plants for the higher THC content. For the other illicit cannabis preparations (hashish and hash oil), there has been only a small number of specimens of these preparations, reflecting the biased preference of the U.S. cannabis market toward the plant material (marijuana and sinsemilla).
Figure S1 in Supplement 1 shows the concentration of THC and other cannabinoids in confiscated hashish samples over time along with the number of specimens by year. Although there is no consistent trend, there has been an increase in the number of hashish specimens over the last 5 years and an increase in the hashish potency over time. Besides THC, the only other cannabinoids with significant content are CBD (generally ,5%) and cannabinol (2%-5%).
Figure S2 in Supplement 1 shows the same data for hash oil samples as for hashish. Over the last few years, there has been an increase in the number of seizures as well as the THC concentration, reaching .50% THC content in the last 3 years. In hash oil samples, the second most significant cannabinoid is cannabinol, not CBD as in hashish. This finding indicates that although an intermediate variety of cannabis (with both THC and CBD) is used in the manufacture of hashish, it appears that hash oil is prepared from drug-type cannabis. With the increased demand for high-potency marijuana, cannabis buds are trimmed where large leaves are removed. It is speculated that those leaves (usually referred to as the "shake" in the cannabis culture) are used to prepare hash oil, which has a higher market value.
DISCUSSION
Although there are several reports concerning the consequences of the use of marijuana, perhaps the most comprehensive is the report by Volkow et al. (6) . These authors detailed the negative health consequences associated with the use of marijuana (especially in early adolescence), including effects on the brain and mental illness, effects on school performance and lifetime achievement, risk of motor vehicle accidents, chronic inflammation of the lungs, and effects on the vascular system. Furthermore, the authors showed that drug-related emergency department visits involving marijuana (either alone or in combination) have increased over time, corresponding to the increase in the potency of the drug over that period of time. The authors noted that with increase in THC content in confiscated marijuana samples from 3% in 1980 to 12% in 2012, the health consequences of marijuana use may be worse now than in the past.
In adolescents 15-17 years old, it was reported that emergency department visits involving marijuana use increased in boys and girls by 53.6% and 42.9%, respectively, from 2005 to 2010 (10). This increase might be caused by the increase in cannabis potency over this time period. Although it might be coincidental or at least empirical that the rate of increase in emergency department admissions almost parallels the rate of increase in cannabis potency over time, the correlation points to the importance of having solid analytical data on cannabis products used by clinicians practicing with medical marijuana in the states that have laws allowing the use of these products.
In conclusion, our data show that the potency of illicit cannabis plant material has consistently increased over the last two decades from approximately 4% in 1995 to approximately 12% in 2014, and a shift in the production of illicit cannabis plant material from regular marijuana to sinsemilla was observed. This increase in potency poses higher risk of cannabis use, particularly among adolescents.
